Additional file 1: Table S1. of Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Aleksandar Sekulic (3192720); Anja Gesierich (4030061); Axel Hauschild (103637); Chris Miller (339314); Christopher Lao (354727); Claus Garbe (48881); Dedee Murrell (4030055); Dirk Schadendorf (103684); Edward McKenna (4030052); Jeannie Hou (4030040); Jorge Quevedo (630146); Laurent Mortier (4030046); Michael Migden (4030049); Natalie Dimier (4030058); Nicole Basset-Seguin (187601); Omid Hamid (4030043); Sarah Williams (2968740)

Additional file 1: Table S1. of Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Authors: Aleksandar Sekulic (3192720)
Anja Gesierich (4030061)
Axel Hauschild (103637)
Chris Miller (339314)
Christopher Lao (354727)
Claus Garbe (48881)
Dedee Murrell (4030055)
Dirk Schadendorf (103684)
Edward McKenna (4030052)
Jeannie Hou (4030040)
Jorge Quevedo (630146)
Laurent Mortier (4030046)
Michael Migden (4030049)
Natalie Dimier (4030058)
Nicole Basset-Seguin (187601)
Omid Hamid (4030043)
Sarah Williams (2968740)
Publication date
Publisher
Doi

Abstract

Investigator-assessed response across patient subgroups (efficacy-evaluable patients). Assessments and demographics for patients with metastatic BCC and locally advanced BCC. (DOCX 16Â kb

Similar works

Full text

Available Versions

FigShare

oai:figshare.com:article/50124...

Last time updated on 12/02/2018